Evome Medical Technologies Inc. (LNDZF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Dec 4, 2025

LNDZF Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023FY 2022FY 2022FY 2021FY 2021
Period Ending
Dec '25 Dec '23 Dec '22 Feb '22 Dec '21 Feb '21
0121821234
Market Cap Growth
-97.57%-31.93%-11.81%-11.05%438.35%15.33%
Enterprise Value
1232222421-2
Last Close Price
0.000.150.350.440.510.13
PS Ratio
0.010.260.621.441.95-164.11
PB Ratio
-0.124.111.622.003.370.83
P/TBV Ratio
-----0.83
P/FCF Ratio
0.08-----
P/OCF Ratio
0.08-----
EV/Sales Ratio
0.340.680.731.681.77-
EV/EBITDA Ratio
---750.80--
EV/FCF Ratio
3.01-----
Debt / Equity Ratio
-5.096.170.830.801.16-
Debt / EBITDA Ratio
---256.75--
Debt / FCF Ratio
3.25-----
Net Debt / Equity Ratio
-4.685.940.710.190.65-1.14
Net Debt / EBITDA Ratio
-4.40-7.83-6.1860.35-7.107.81
Net Debt / FCF Ratio
2.99-21.18-6.15-0.66-1.417.76
Asset Turnover
0.941.250.840.66--
Inventory Turnover
2.994.374.21---
Quick Ratio
0.180.230.280.630.381.17
Current Ratio
0.510.560.550.870.562.02
Return on Equity (ROE)
-294.80%-161.40%-158.35%-44.17%--33.06%
Return on Assets (ROA)
-6.67%-6.88%-4.16%-1.36%--5.60%
Return on Capital Employed (ROCE)
-432.80%-51.70%-14.50%-3.10%-9.10%-15.40%
Earnings Yield
-5782.48%-94.81%-76.98%-16.62%-16.91%-48.45%
FCF Yield
1319.12%-6.82%-7.11%-14.29%-13.63%-17.71%
Buyback Yield / Dilution
-28.35%-33.97%-25.70%-1.90%-26.68%-0.03%
Total Shareholder Return
-28.35%-33.97%-25.70%-1.90%-26.68%-0.03%
Updated Nov 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.